Diabetes mellitus is a metabolic disorder that arises due to high blood glucose levels. This condition occurs due to the absence of insulin, a hormone responsible for regulating blood sugar. The WHO projects that diabetes will be the seventh leading cause of death by 2030. Lancets are the most commonly used alternative devices to obtain blood samples. These devices are easily acceptance y globally due to their convenient characteristics that provide them an advantage over traditional methods used for vein puncture.
MARKET DYNAMICS
The diabetic lancing device market is driving due to the growing prevalence of chronic diseases and cancer and the increasing demand for cell therapies for the treatment of these diseases. Moreover, the increase in prevalence of diabetes is expected to result in rise in demand for devices and products to monitor and control the disease, eventually leading to increased consumption of lancets.
MARKET SCOPE
The "Diabetic Lancing Device Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetic lancing device market with detailed market segmentation by type, gauge, penetration depth and end user. The diabetic lancing device market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetic lancing device market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The diabetic lancing device market is segmented on the basis of type, gauge, penetration depth and end user. Based on type, the market is segmented as safety lancets and standard lancets. On the basis of gauge, the market is categorized as 17/18g, 21g, 23g, and others. On the basis of penetration depth, the market is categorized as 0.8 mm to 1.0 mm, 1.1 mm to 1.5 mm, 1.6 mm to 2.0 mm, and others. On the basis of end user, the market is categorized as hospitals & clinics, home care & home diagnostics, diagnostic centers & medical institutions, research & academic laboratories, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the diabetic lancing device market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetic lancing device market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diabetic lancing device market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the diabetic lancing device market in these regions.
MARKET PLAYERS
The report covers key developments in the diabetic lancing device market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from diabetic lancing device market are anticipated to have lucrative growth opportunities in the future with the rising demand for diabetic lancing device in the global market. Below mentioned is the list of few companies engaged in the diabetic lancing device market.
The report also includes the profiles of key players in diabetic lancing device market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories,
- B. Braun Melsungen AG
- Bayer AG
- Becton Dickinson
- Eli Lilly and Company
- F. Hoffmann-La Roche AG
- HTL-STREFA S.A
- Medtronic
- Novo Nordisk A/S Owen Mumford Ltd
- Sanofi
- Sarstedt AG & Co
- Terumo Corporation
- Ypsomed Holding AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.